Skip to main content

Osteoarthritis clinical trials at UC Davis
1 research study open to eligible people

  • Study to Determine the Safety and the Effectiveness of Experimental Fasinumab in Patients With Knee or Hip Osteoarthritis Pain

    “This study is being done to see how effective and safe fasinumab (REGN475) is for the treatment of pain caused by Osteoarthritis.”

    open to eligible people ages 18 years and up

    The primary objective of the study is to evaluate the efficacy of fasinumab compared to placebo, when administered for up to 24 weeks in patients with pain due to osteoarthritis (OA) of the knee or hip. The secondary objectives of the study are: - To evaluate the efficacy of fasinumab compared to non-steroidal anti-inflammatory drugs (NSAID)s, when administered for up to 24 weeks in patients with pain due to OA of the knee or hip - To assess the safety and tolerability of fasinumab compared to placebo and compared to NSAIDs, when administered for up to 24 weeks in patients with pain due to OA of the knee or hip

    Sacramento, California and other locations